Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund, Dortmund, Germany.
Division of Theoretical Bioinformatics, German Cancer Research Center and BioQuant Center, Heidelberg, Germany.
J Exp Med. 2019 Sep 2;216(9):2113-2127. doi: 10.1084/jem.20181454. Epub 2019 Jul 3.
NK cells eliminate virus-infected and tumor cells by releasing cytotoxic granules containing granzyme B (GrzB) or by engaging death receptors that initiate caspase cascades. The orchestrated interplay between both cell death pathways remains poorly defined. Here we simultaneously measure the activities of GrzB and caspase-8 in tumor cells upon contact with human NK cells. We observed that NK cells switch from inducing a fast GrzB-mediated cell death in their first killing events to a slow death receptor-mediated killing during subsequent tumor cell encounters. Target cell contact reduced intracellular GrzB and perforin and increased surface-CD95L in NK cells over time, showing how the switch in cytotoxicity pathways is controlled. Without perforin, NK cells were unable to perform GrzB-mediated serial killing and only killed once via death receptors. In contrast, the absence of CD95 on tumor targets did not impair GrzB-mediated serial killing. This demonstrates that GrzB and death receptor-mediated cytotoxicity are differentially regulated during NK cell serial killing.
NK 细胞通过释放含有颗粒酶 B (GrzB) 的细胞毒性颗粒或通过与起始半胱天冬酶级联反应的死亡受体结合来消除病毒感染和肿瘤细胞。这两种细胞死亡途径之间的协调相互作用仍未得到很好的定义。在这里,我们同时测量了人类 NK 细胞与肿瘤细胞接触时 GrzB 和 caspase-8 在肿瘤细胞中的活性。我们观察到,NK 细胞在其首次杀伤事件中从诱导快速的 GrzB 介导的细胞死亡转变为在随后的肿瘤细胞接触中进行缓慢的死亡受体介导的杀伤。靶细胞接触会随着时间的推移减少 NK 细胞内的 GrzB 和穿孔素,并增加表面 CD95L,表明细胞毒性途径的转换是如何受到控制的。没有穿孔素,NK 细胞就无法进行 GrzB 介导的连续杀伤,只能通过死亡受体进行一次杀伤。相比之下,肿瘤靶标上缺乏 CD95 并不影响 GrzB 介导的连续杀伤。这表明 GrzB 和死亡受体介导的细胞毒性在 NK 细胞连续杀伤过程中受到不同的调节。